These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

601 related items for PubMed ID: 17602907

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
    Szewczuk MR, Depew WT.
    Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
    [Abstract] [Full Text] [Related]

  • 4. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
    Griga T, Voigt E, Gretzer B, Brasch F, May B.
    Hepatogastroenterology; 1999 Feb; 46(26):920-3. PubMed ID: 10370639
    [Abstract] [Full Text] [Related]

  • 5. Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease.
    McKaig BC, McWilliams D, Watson SA, Mahida YR.
    Am J Pathol; 2003 Apr; 162(4):1355-60. PubMed ID: 12651627
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T, May B, Pfisterer O, Müller KM, Brasch F.
    Hepatogastroenterology; 2002 Apr; 49(43):116-23. PubMed ID: 11941933
    [Abstract] [Full Text] [Related]

  • 7. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group.
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [Abstract] [Full Text] [Related]

  • 8. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L, Kuiper I, Lamers CB, Verspaget HW.
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [Abstract] [Full Text] [Related]

  • 9. The association of MYO9B gene in Italian patients with inflammatory bowel diseases.
    Latiano A, Palmieri O, Valvano MR, D'Incà R, Caprilli R, Cucchiara S, Sturniolo GC, Bossa F, Andriulli A, Annese V.
    Aliment Pharmacol Ther; 2008 Feb 01; 27(3):241-8. PubMed ID: 17944996
    [Abstract] [Full Text] [Related]

  • 10. Differential mucosal expression of three superoxide dismutase isoforms in inflammatory bowel disease.
    Kruidenier L, Kuiper I, van Duijn W, Marklund SL, van Hogezand RA, Lamers CB, Verspaget HW.
    J Pathol; 2003 Sep 01; 201(1):7-16. PubMed ID: 12950012
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intestinal mucosa diamine oxidase activity reflects intestinal involvement in Crohn's disease.
    Thompson JS, Burnett DA, Markin RS, Vaughan WP.
    Am J Gastroenterol; 1988 Jul 01; 83(7):756-60. PubMed ID: 3132852
    [Abstract] [Full Text] [Related]

  • 13. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S, Weidenhiller M, Otte P, Stolper J, Schwab D, Hahn EG, Raithel M.
    Am J Gastroenterol; 2002 Dec 01; 97(12):3071-7. PubMed ID: 12492192
    [Abstract] [Full Text] [Related]

  • 14. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
    Tsiolakidou G, Koutroubakis IE, Tzardi M, Kouroumalis EA.
    Dig Liver Dis; 2008 Aug 01; 40(8):673-9. PubMed ID: 18374637
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Familial prevalence in chronic intestinal inflammatory disease. Differences among groups of patients with and without a familial history].
    Nos P, Argüello L, Hoyos M, Ramírez JJ, Hinojosa J, Molés JR, García A, Berenguer M, Berenguer J.
    Rev Esp Enferm Dig; 1996 Jul 01; 88(7):470-4. PubMed ID: 8924324
    [Abstract] [Full Text] [Related]

  • 17. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH, Lin KC, Yu DT, Yang C, Huang F, Chen HA, Liang TH, Liao HT, Tsai CY, Wei JC, Chou CT.
    Rheumatology (Oxford); 2006 Apr 01; 45(4):414-20. PubMed ID: 16287916
    [Abstract] [Full Text] [Related]

  • 18. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.
    Jenkins D, Seth R, Kummer JA, Scott BB, Hawkey CJ, Robins RA.
    J Pathol; 2000 Feb 01; 190(2):184-9. PubMed ID: 10657017
    [Abstract] [Full Text] [Related]

  • 19. A new approach using tissue alkaline phosphatase histochemistry to identify Crohn's disease.
    Torres MI, Lorite P, López-Casado MA, Ríos A.
    Pathol Res Pract; 2007 Feb 01; 203(6):485-7. PubMed ID: 17498884
    [Abstract] [Full Text] [Related]

  • 20. Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation.
    Mazzucchelli L, Hauser C, Zgraggen K, Wagner H, Hess M, Laissue JA, Mueller C.
    Am J Pathol; 1994 May 01; 144(5):997-1007. PubMed ID: 8178948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.